

















































































































































































































































































































































































































































































Figure 1. The steps involved in the process of MP formation. a) Demonstrating a healthy membrane, with phospholipid asymmetry and the 
presence of the regulatory enzyme floppase (interchangeable in this diagram with the other regulatory enzymes mentioned). b) Activation or 
apoptotic stimuli causes fluctuations of cytosolic calcium, altering the activity of the regulatory enzymes and causing cytoskeletal disruption. c) 
Membrane blebbing, and loss of phospholipid asymmetry resulting in externalisation of phosphatidylserine. d) Fissure of the membrane, 
resulting in the formation of an MP which is now a distinct vesicle from its original membrane. This MP will express surface antigens 
representative of its parent cell, which can be assessed to identify the origin of the MP. The MP size and number of phospholipids present in 
the membrane in Figure d) is not truly representative; the purpose of this diagram is to illustrate the formation process. In reality, the MP is of 
far greater size relative to the phospholipids, which are also present in far greater abundance in the MP membrane.  
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Figure 2. Examples of the immunologic signalling mechanisms MPs utilise to facilitate their bioeffector functions. Included are 
the typical pathways that these mechanisms iniƟate, and the typical end result. ● = signalling mechanism, ◊ = typical 
physiological consequence. 
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